BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26105248)

  • 1. OS034. Magnesium sulfate for prevention of eclampsia: Are intramuscularand intravenous regimens equivalent?
    Easterling T; Salinger D; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P
    Pregnancy Hypertens; 2012 Jul; 2(3):194. PubMed ID: 26105248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
    Salinger DH; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P; Easterling T
    BJOG; 2013 Jun; 120(7):894-900. PubMed ID: 23530757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PP164. Magnesium sulphate for prevention and treatment of eclampsia in low and middle income countries: Systematic review of tested regimens.
    Gordon RM; Payne B; Firoz T; Magee L; Sawchuck D; Tu D; Vidler M; von Dadelszen P;
    Pregnancy Hypertens; 2012 Jul; 2(3):328. PubMed ID: 26105485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial.
    Abdul MA; Nasir UI; Khan N; Yusuf MD
    Arch Gynecol Obstet; 2013 Jan; 287(1):43-6. PubMed ID: 22930148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia.
    Chissell S; Botha JH; Moodley J; McFadyen L
    S Afr Med J; 1994 Sep; 84(9):607-10. PubMed ID: 7839282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.
    Du L; Wenning L; Migoya E; Xu Y; Carvalho B; Brookfield K; Witjes H; de Greef R; Lumbiganon P; Sangkomkamhang U; Titapant V; Duley L; Long Q; Oladapo OT
    J Clin Pharmacol; 2019 Mar; 59(3):374-385. PubMed ID: 30422321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia.
    Chowdhury JR; Chaudhuri S; Bhattacharyya N; Biswas PK; Panpalia M
    J Obstet Gynaecol Res; 2009 Feb; 35(1):119-25. PubMed ID: 19215558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial.
    Brookfield KF; Tuel K; Rincon M; Vinson A; Caughey AB; Carvalho B
    Obstet Gynecol; 2020 Dec; 136(6):1190-1194. PubMed ID: 33156201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia.
    Brookfield K; Galadanci H; Du L; Wenning L; Mohammed I; Suleiman M; Oladapo OT; Witjes H; Carvalho B
    AJOG Glob Rep; 2021 Nov; 1(4):100018. PubMed ID: 36277458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial.
    Manorot M; Tongsong T; Khettglang T
    J Med Assoc Thai; 1996 Feb; 79(2):76-82. PubMed ID: 8868017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.
    Lucas MJ; Leveno KJ; Cunningham FG
    N Engl J Med; 1995 Jul; 333(4):201-5. PubMed ID: 7791836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour.
    Charoenvidhya D; Manotaya S
    J Med Assoc Thai; 2013 Apr; 96(4):395-8. PubMed ID: 23691692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy.
    Aali BS; Khazaeli P; Ghasemi F
    J Obstet Gynaecol Res; 2007 Apr; 33(2):138-43. PubMed ID: 17441885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia.
    Bhattacharjee N; Saha SP; Ganguly RP; Patra KK; Dhali B; Das N; Barui G
    J Obstet Gynaecol; 2011 May; 31(4):298-303. PubMed ID: 21534749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success?
    Dayicioglu V; Sahinoglu Z; Kol E; Kucukbas M
    Hypertens Pregnancy; 2003; 22(3):257-65. PubMed ID: 14572362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loading dose versus standard regimen of magnesium sulphate in eclampsia--a randomized trial.
    Regmi MC; Aggrawal A; Pradhan T; Rijal P; Subedi A; Uprety D
    Nepal Med Coll J; 2010 Dec; 12(4):244-7. PubMed ID: 21744767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium sulphate is the drug of choice for eclampsia.
    Safe Mother; 1995; (18):3, 13. PubMed ID: 12347352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zuspan's scheme versus an alternative magnesium sulfate scheme: Randomized clinical trial of magnesium serum concentrations.
    Abbade JF; Costa RA; Martins AM; Borges VT; Rudge MV; Peraçoli JC
    Hypertens Pregnancy; 2010 Jan; 29(1):82-92. PubMed ID: 20132023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate.
    Mundle S; Regi A; Easterling T; Biswas B; Bracken H; Khedekar V; Ratna Shekhavat D; Durocher J; Winikoff B
    Pregnancy Hypertens; 2012 Jan; 2(1):32-8. PubMed ID: 26104987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is magnesium sulfate for prevention or only therapeutic in preeclampsia?
    Tannirandorn Y
    J Med Assoc Thai; 2005 Jul; 88(7):1003-10. PubMed ID: 16241034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.